FIELD: medicine.
SUBSTANCE: invention relates to methods of purifying and/or viral inactivation of FSH (follicle-stimulating hormone), hCG (human chorionic gonadotrophin) or LH (luteinising hormone), comprising the step of treating FSH, hCG or LH with a combination of caprylic acid and ethanol and incubating the treated FSH, hCG or LH.
EFFECT: method provides effective purification with high output and viral inactivation.
12 cl, 3 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCOPROTEIN HORMONE LONG-ACTING SUPERAGONISTS | 2013 |
|
RU2668174C2 |
| FSH STABILISATION | 2011 |
|
RU2574012C2 |
| PHARMACEUTICAL PREPARATION CONTAINING RECOMBINANT HUMAN CHORIONIC GONADOTROPIN | 2010 |
|
RU2588650C2 |
| DERIVATIVES OF THIENO[2,3-D]PYRIMIDINE AND THEIR USING IN TREATMENT OF FERTILITY DISORDER | 2002 |
|
RU2298011C2 |
| PHARMACEUTICAL PREPARATION CONTAINING RECOMBINANT HCG (HUMAN CHORIONIC GONADOTROPIN HORMONE) | 2010 |
|
RU2724528C2 |
| FLUID FORMULATION OF FOLLICLE-STIMULATING HORMONE | 2011 |
|
RU2553375C2 |
| UNITARY COMBINATION OF FSH AND hCG | 2004 |
|
RU2332228C2 |
| COMPOSITION FOR TREATING INFERTILITY | 2016 |
|
RU2704252C2 |
| RECOMBINANT FOLLICLE-STIMULATING HORMONE (FSH) CONTAINING ALPHA-2, 3- AND ALPHA-2, 6-SYALILATION | 2009 |
|
RU2537268C2 |
| RECOMBINANT CHORIONIC GONADOTROPIN, A METHOD OF ITS PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | 2019 |
|
RU2803047C1 |
